Polaris Venture Partners V L.P. 13D and 13G filings for Kala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-02-12 4:55 pm Sale | 2019-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA | Polaris Venture Partners V L.P. | 23,945 1.700% | -51,692 (-68.34%) | Filing |